These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17623515)

  • 1. The metabolic syndrome in HIV-seropositive patients.
    Kell P
    Int J STD AIDS; 2007 Jul; 18(7):507-8. PubMed ID: 17623515
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Cohen PG
    J Urol; 2006 Jun; 175(6):2366; author reply 2367. PubMed ID: 16697878
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic syndrome and hypogonadism--two peas in a pod.
    Ebrahimi F; Christ-Crain M
    Swiss Med Wkly; 2016; 146():w14283. PubMed ID: 26999489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nebido in the treatment of hypogonadism syndrome and its complications in men].
    Dedov II; Kurbatov DG; Rozhivanov RV; Lepetukhin AE; Dubskiĭ SA; Goncharov NP
    Urologiia; 2011; (6):59-60, 62-7. PubMed ID: 22448484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the German version of the 'Hypogonadism Related Symptom Scale' (HRS) in andrological patients with infertility, HIV infection and metabolic syndrome.
    Alidjanov J; Wolf J; Schuppe HC; Weidner W; Diemer T; Linn T; Halefeldt I; Wagenlehner F; Wiltink J; Pilatz A
    Andrologia; 2014 Dec; 46(10):1189-97. PubMed ID: 24387031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unexplained anaemia in men: be aware of hypogonadism].
    van de Meerendonk HW; Mijnhout GS; Groeneveld PH
    Ned Tijdschr Geneeskd; 2012; 155(31):A4633. PubMed ID: 22853762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS.
    Rabkin JG; Rabkin R; Wagner GJ
    Int J STD AIDS; 1997 Sep; 8(9):537-45. PubMed ID: 9292341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between sex hormones and the metabolic syndrome.
    Lunenfeld B
    Acta Biomed; 2010; 81 Suppl 1():79-84. PubMed ID: 20518195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement for hypogonadism: clinical findings and best practices.
    Hengge UR
    AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deficiency, diabetes, and the metabolic syndrome in men.
    Kalyani RR; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):226-34. PubMed ID: 17940444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
    Morelli A; Comeglio P; Filippi S; Sarchielli E; Cellai I; Vignozzi L; Yehiely-Cohen R; Maneschi E; Gacci M; Carini M; Adorini L; Vannelli GB; Maggi M
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):80-92. PubMed ID: 22406511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of testosterone substitution on metabolic syndrome-related factors in hypogonadal males: a meta-analysis].
    Wan ZH; Wen YB; Ding QF; Xu TY
    Zhonghua Nan Ke Xue; 2010 Jun; 16(6):510-5. PubMed ID: 20608354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testosterone and bone: indications and limitations].
    Stoll D; Puder JJ; Lamy O
    Rev Med Suisse; 2011 Jun; 7(299):1311-5. PubMed ID: 21793421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.